Pharmacoepidemiological analysis of the effect of lipid-lowering therapy on cardiovascular mortality in the regions of the Russian Federation
Objectives. Cardiovascular diseases (CVD) are one of the leading causes of death worldwide, including Russia. According to the data obtained from the ESSE-RF study, the most common risk factor for the development of CVD is high level of cholesterol. At the same time, among drugs that lower cholester...
Main Authors: | I. S. Krysanov, V. S. Krysanova, V. Yu. Ermakova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Izdatelstvo OKI
2022-08-01
|
Series: | Качественная клиническая практика |
Subjects: | |
Online Access: | https://www.clinvest.ru/jour/article/view/617 |
Similar Items
-
Analysis of the drug prescription for obese patients in Moscow
by: V. S. Krysanova, et al.
Published: (2020-05-01) -
STRESS: WHAT WE ACTUALLY KNOW ABOUT THIS RISK FACTOR?
by: R. G. Oganov, et al.
Published: (2015-12-01) -
Cardiovascular safety of febuxostat. Analysis of the CARES study
by: M. S. Eliseev
Published: (2018-12-01) -
Main directions of prophylaxis of untimely mortality from cardiovascular diseases
by: A. T. Adamyan, et al.
Published: (2009-04-01) -
Pilot project to study the association of troponin I with cardiovascular events in the population of Russian region
by: S. A. Shalnova, et al.
Published: (2021-09-01)